6-161048884-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005922.4(MAP3K4):c.612G>A(p.Met204Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000261 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005922.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K4 | NM_005922.4 | c.612G>A | p.Met204Ile | missense_variant | 3/27 | ENST00000392142.9 | NP_005913.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP3K4 | ENST00000392142.9 | c.612G>A | p.Met204Ile | missense_variant | 3/27 | 1 | NM_005922.4 | ENSP00000375986 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000120 AC: 30AN: 250810Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135550
GnomAD4 exome AF: 0.000267 AC: 390AN: 1461850Hom.: 0 Cov.: 34 AF XY: 0.000242 AC XY: 176AN XY: 727226
GnomAD4 genome AF: 0.000210 AC: 32AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2023 | The c.612G>A (p.M204I) alteration is located in exon 3 (coding exon 3) of the MAP3K4 gene. This alteration results from a G to A substitution at nucleotide position 612, causing the methionine (M) at amino acid position 204 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at